MRI-based tool to tell uterine sarcoma from fibroids
Part of Cancer, Skin clinical trials.
This trial uses MRI scans to see if a computer can tell the difference between uterine sarcoma (a rare cancer) and fibroids (non-cancerous growths). If you've already been diagnosed with one of these and had an MRI before surgery, you may be able to help.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with uterine sarcoma or a fibroid (leiomyoma) after a biopsy.
- You had an MRI scan of your pelvis within 2 months before your surgery.
- The MRI included special sequences called T2-weighted and diffusion-weighted imaging.
- Your tumor must be at least 2 centimeters (about the size of a grape).
- The sarcoma started in your uterus, not elsewhere in your body.
- You do not have another type of cancer in your pelvis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses MRI scans and computer analysis to help tell the difference between benign uterine fibroids and a rare cancer called uterine sarcoma. If you qualify, you'll be followed over time to see how accurate the test is.
This study tests an AI tool that reads non-contrast breast MRI images to help find breast cancer earlier, especially in women who can't have contrast dye. You don't get extra scans — the AI reviews your existing MRI and checks its accuracy against your medical outcome.
This study tests whether MRI scans can replace CT scans to map bone tumors and plan surgery. If successful, it may allow some patients to avoid CT radiation.
This study uses a special type of MRI scan to look at growths in the uterus and tries to figure out if they are harmless or cancerous, without needing surgery. It compares the MRI results with a biopsy to see how accurate the scan is.
This trial tests a computer model that learns from MRI scans to predict prostate cancer. If you have had a prostate MRI showing suspicious areas and are scheduled for a biopsy, joining may help improve how cancer is detected.
This trial uses MRI scans to create a model that may predict if a musculoskeletal tumor is spreading. It aims to help doctors decide on the best surgical treatment.
Hear when a new Uterine Sarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.